A new trading day began on Friday, with Tenaya Therapeutics Inc (NASDAQ: TNYA) stock price down -3.97% from the previous day of trading, before settling in for the closing price of $1.26. TNYA’s price has ranged from $0.99 to $7.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 19.60%. With a float of $65.64 million, this company’s outstanding shares have now reached $79.22 million.
Let’s determine the extent of company efficiency that accounts for 140 employees. In terms of profitability, gross margin is 58.87%, operating margin of -694.87%, and the pretax margin is -663.65%.
Tenaya Therapeutics Inc (TNYA) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tenaya Therapeutics Inc is 17.15%, while institutional ownership is 57.48%. The most recent insider transaction that took place on Nov 18 ’24, was worth 4,787. In this transaction SVP, Accounting and Fin. Ops. of this company sold 2,258 shares at a rate of $2.12, taking the stock ownership to the 60,983 shares. Before that another transaction happened on Aug 16 ’24, when Company’s SVP, Accounting and Fin. Ops. sold 2,363 for $2.89, making the entire transaction worth $6,840. This insider now owns 63,241 shares in total.
Tenaya Therapeutics Inc (TNYA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 19.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.78% during the next five years compared to -27.43% drop over the previous five years of trading.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Here are Tenaya Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Looking closely at Tenaya Therapeutics Inc (NASDAQ: TNYA), its last 5-days average volume was 1.84 million, which is a drop from its year-to-date volume of 2.11 million. As of the previous 9 days, the stock’s Stochastic %D was 11.61%. Additionally, its Average True Range was 0.18.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 7.39%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.85% in the past 14 days, which was lower than the 161.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.1570, while its 200-day Moving Average is $2.8855. However, in the short run, Tenaya Therapeutics Inc’s stock first resistance to watch stands at $1.2567. Second resistance stands at $1.3033. The third major resistance level sits at $1.3267. If the price goes on to break the first support level at $1.1867, it is likely to go to the next support level at $1.1633. Should the price break the second support level, the third support level stands at $1.1167.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
With a market capitalization of 95.86 million, the company has a total of 79,221K Shares Outstanding. Currently, annual sales are 0 K while annual income is -124,080 K. The company’s previous quarter sales were 0 K while its latest quarter income was -25,630 K.
